Cargando…

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage

Postpartum hemorrhage (PPH) is the commonest cause of maternal death worldwide. Studies suggest that the use of misoprostol may be beneficial in clinical settings where oxytocin is unavailable. The aim of this study was to compare the safety and efficacy of oxytocin and misoprostol when used in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajaei, Minoo, Karimi, Samieh, Shahboodaghi, Zohreh, Mahboobi, Hamidreza, Khorgoei, Tahereh, Rajaei, Farzam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964754/ https://www.ncbi.nlm.nih.gov/pubmed/24734184 http://dx.doi.org/10.1155/2014/713879

Ejemplares similares

Misoprostol versus High Dose Oxytocin and Laminaria in Termination of Pregnancy in Second Trimester Pregnancies
por: Alavi, Azin, et al.
Publicado: (2013)

Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Xu, Renmei, et al.
Publicado: (2022)

Retracted: Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Oxytocin Versus Misoprostol Plus Oxytocin in the Prevention of Postpartum Hemorrhage at a Semi-Urban Hospital in sub-Saharan Africa: A Retrospective Cohort Study
por: Numfor, Emmanuel, et al.
Publicado: (2020)

Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial
por: Atukunda, Esther C., et al.
Publicado: (2014)

Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population
por: Karimi, Samieh, et al.
Publicado: (2012)

Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013)

Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial
por: Sringamwong, Wirawan, et al.
Publicado: (2022)

Role of soap and water in the treatment of wound dehiscence compared to normal saline plus povidone-iodine: A randomized clinical trial
por: Najafian, Aida, et al.
Publicado: (2015)

Hot climate and elderly surgical patients
por: Yazdani, Reza, et al.
Publicado: (2011)

Two important issues in writing an abstract
por: Mahboobi, Hamidreza, et al.
Publicado: (2012)

Lifestyle changes for prevention of breast cancer
por: Hashemi, Seyed Hesam Bani, et al.
Publicado: (2014)

Effects of a New Patient Safety-Driven Oxytocin Dosing Protocol on Postpartum Hemorrhage
por: McKenna, David S., et al.
Publicado: (2014)

Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trial
por: Bracken, Hillary, et al.
Publicado: (2021)

Attitudes and communication skills
por: Mahboobi, Hamidreza, et al.
Publicado: (2011)

Neurologists’ role in antimicrobial resistance
por: Mahboobi, Hamidreza, et al.
Publicado: (2012)

Tic and Obsessive Compulsive Disorder: Two Common ADHD Co-morbidities
por: Golmirzaei, Javad, et al.
Publicado: (2012)

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention
por: Prata, Ndola, et al.
Publicado: (2014)

Current form of randomized controlled trials
por: Hamidreza, Mahboobi, et al.
Publicado: (2011)

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
por: Cook, John R., et al.
Publicado: (2023)

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach
por: Koch, Daeska Marcella, et al.
Publicado: (2019)

Outcome of misoprostol and oxytocin in induction of labour
por: Acharya, Trishna, et al.
Publicado: (2017)

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2015)

Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience
por: Haver, Jaime, et al.
Publicado: (2016)

Correction: Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2016)

Quality of oxytocin and misoprostol in health facilities of Rwanda
por: Bizimana, Thomas, et al.
Publicado: (2021)

Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage
por: Zgaya, Rym, et al.
Publicado: (2020)

Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial
por: Adnan, Nita, et al.
Publicado: (2017)

Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date
por: Smith, Jeffrey Michael, et al.
Publicado: (2013)

Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia
por: Smith, Jeffrey Michael, et al.
Publicado: (2014)

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi
por: Hagen, Nhomsai, et al.
Publicado: (2020)

A randomized controlled trial comparing isosorbide dinitrate-oxytocin versus misoprostol-oxytocin at management of foetal intrauterine death
por: Arteaga-Troncoso, Gabriel, et al.
Publicado: (2019)

Feasibility, Acceptability, and Programme Effectiveness of Misoprostol for Prevention of Postpartum Haemorrhage in Rural Bangladesh: A Quasiexperimental Study
por: Quaiyum, Abdul, et al.
Publicado: (2014)

Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage
por: Lambert, Peter, et al.
Publicado: (2020)

Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study)
por: van der Nelson, Helen, et al.
Publicado: (2019)

Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?
por: Chatterjee, Susmita, et al.
Publicado: (2016)

Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning
por: Prata, Ndola, et al.
Publicado: (2016)

Foley Catheter versus Vaginal Misoprostol for Labour Induction
por: Noor, Nasreen, et al.
Publicado: (2015)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial
por: Mannaerts, D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i0f15e6qbd55h3fnpkfv9chkab